MedPath
HSA Approval

UNILAX TABLET 5 mg

SIN03319P

UNILAX TABLET 5 mg

UNILAX TABLET 5 mg

June 8, 1989

DEWS LIFE SCIENCES PTE. LTD.

DEWS LIFE SCIENCES PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDEWS LIFE SCIENCES PTE. LTD.
Licence HolderDEWS LIFE SCIENCES PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

A06AB02

bisacodyl

Manufacturer Information

DEWS LIFE SCIENCES PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

BISACODYL

5 mg

Bisacodyl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UNILAX TABLET 5 mg - HSA Approval | MedPath